CD24 and neoplasm: After correcting tumor volume based on luciferase (LUC) bioluminescence (Fig. 4D), quantitative comparison revealed that orthotopic tumors in the dEM-CD24-treated group exhibited more than a twofold increase in fluorescence intensity compared to those treated with dEM (Fig. 4E), confirming its tumor-selective delivery capability.